CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Increases in NfL concentrations have been reported in individuals with other neurodegenerative diseases, such as Alzheimer’s and Huntington’s diseases, and in indications beyond neurology.
Elecsys NfL has the potential to help scale multiple sclerosis testing on automated and standardized Roche Cobas instruments.
The FDA last year also granted breakthrough device designation to Roche’s Elecsys Amyloid Plasma Panel.
Abbott HPV test approved for use as primary screen
Abbott received Food and Drug Administration approval for its Alinity m high-risk HPV assay.
The assay is approved as a test for HPV detection and for use in routine cervical cancer screening as per medical guidelines. It is also approved for use in cotesting. It provides information on five risk groups covering the 14 potentially cancer-causing genotypes of the virus.
“The Alinity m HR HPV assay was carefully designed to support patient care and streamline HPV testing,” Keith Cienkus, Abbott vice president of molecular business, said in a Nov. 2 news release.